Page 147 - boneArtis - Digital Catalog
P. 147

                 Synthacer® / Syntricer® Bone Void Filler
Synthacer® and Syntricer® are indicated for the treat- ment of surgical bone defects or defects of another pathogenesis:
- Bone void  lling of defects caused by traumata
- Filling of bone voids a er gathering of autologous cancellous bone, i.e. the iliac crest or donor defects in the trochlea patellae or other donor regions.
- Bone void  lling and augmenta on in maxilla-facial surgery.
“Clinical evidence con rms the following product prop- er es”:
- Bone void  lling
- Osteoconduc on
- Radiopaque material - Biocompa bility
- Purity of the material.
Only Syntricer®:
- nearly complete biodegrada on within 3 – 4 months
depending upon the turn-over rate
Only Synthacer®:
- slow (insigni cant) biodegrada on
Up un l today, no interac on between Syntricer® and Synthacer® products and drugs or other medical devic- es has been observed, with the excep on of the direct combina on with s   implants.
Synthacer®/Syntricer® is therefore used in Traumatolo- gy, Orthopaedic Surgery, Reconstruc ve Surgery, Max- illo-Facial Surgery and Oto-Rhino-Laryngology, i.e. for reconstruc on of the “mastoid process”.
The material is used in all kinds of bone defects where shear, tension as well as torsion and high compres- sive forces can be ignored. “Ceramic disease”, caused by rela ve micro-movements of the ceramic par cles or by s   implants (screws, metal implants etc.), can be avoided with a combina on of materials providing damping proper es, i.e. morsellized bone preferably of the same size or by a recipient bed with an intact can- cellous bone environment. This results in the so-called
REV0116112017EN
145















































































   145   146   147   148   149